Compare ACNT & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACNT | ORMP |
|---|---|---|
| Founded | 1945 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.0M | 141.3M |
| IPO Year | 1995 | 2010 |
| Metric | ACNT | ORMP |
|---|---|---|
| Price | $13.15 | $3.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 181.0K | 107.4K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 7.35% |
| EPS Growth | 106.72 | ★ 412.50 |
| EPS | 0.09 | ★ 1.50 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $147.89 | ★ $2.27 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $11.62 | $1.82 |
| 52 Week High | $17.92 | $3.76 |
| Indicator | ACNT | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 41.46 | 48.77 |
| Support Level | $11.91 | $3.21 |
| Resistance Level | $16.80 | $3.72 |
| Average True Range (ATR) | 0.43 | 0.18 |
| MACD | 0.20 | -0.02 |
| Stochastic Oscillator | 80.81 | 33.33 |
Ascent Industries Co specializes in development, production, and distribution of specialty chemicals. The company produces specialty ingredients and products for the oil and gas, household, industrial and institutional, personal care, coatings, adhesive, sealants, elastomers, pulp and paper, textile, automotive, agricultural, water, treatment, and construction industries. The products of the company include: Surfactants, Defoamers, Flame Retardants, Emulsifiers, Lubricants, Plasticizers, Straight Esters and Others.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.